Cardiovascular devices are used in treating diseases related to the heart and the circulatory system. A stent is an expandable perforated tube that is inserted into a natural conduit of the body to prevent or counteract a disease-induced localized flow constriction. GlobalData uses proprietary data and analytics to provide a comprehensive report on the coronary stents market in Belgium. Buy the latest report here.
Smarter leaders trust GlobalData
In 2022, GlobalData’s Market Model methodology determined that the leading player in the coronary stents market in Belgium was Abbott Laboratories followed by B. Braun Melsungen, Biotronik SE & Co, Boston Scientific, Lepu Medical Technology (Beijing), Medtronic, Meril Life Sciences, MicroPort Scientific, Sahajanand Medical Technologies, Translumina Therapeutics and Vascular Concepts.
Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments.
The main goal of the stent is to hold the inner wall in its compressed position and retain the enlarged vessel diameter. Coronary stents are used in the coronary vasculature and include bioabsorbable stents (BAS), drug eluting stents (DES), bare metal stents (BMS) and covered stents. Coronary stent system consists of a stent and balloon catheter delivery system. Coronary bare metal stents are uncoated stents that are permanently placed inside the artery. Coronary drug eluting stents release drugs locally and can be coated with a polymeric material. Coronary covered stents have a metal skeleton with an extra accessory or cover which is made up of fabric or graft material. Coronary bioabsorbable stents are also known as bioresorbable or biodegradable coronary stents.
The coronary stents market in Belgium can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice.
For the latest analysis of the market size coronary stents in Belgium, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s Medical Intelligence Center Market Models are the gold standard of medical device market valuation, company share estimation and market trend forecasting. GlobalData uses a patient-based forecast model or installed base methodology to determine the market size for therapeutic indications and capital equipment expenditures. Estimates are based on a number of sources, including primary research—KOL and industry contact interviews—and secondary research, such as company reports, press releases, published articles, proprietary databases, and general news media.
